Literature DB >> 2029879

A reanalysis of the Stanton et al. pleural sarcoma data.

G W Oehlert1.   

Abstract

An analysis of the Stanton et al. (1981, J. Natl. Cancer Inst. 67, 965-975) data reconfirms number of index particles as the primary dimensional predictor of tumor incidence. Fitting separate intercepts and/or slopes to each mineral type results in substantial significant improvement in fit, indicating the importance of mineral type. This contrasts with the "Stanton hypothesis," which states that dimensional properties alone determine carcinogenesis. Log mean aspect ratio is not as good a predictor of tumor incidence as the number of index particles; among those samples that did not have index particles, log mean aspect ratio is not a significant predictor of tumor incidence.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2029879     DOI: 10.1016/s0013-9351(05)80101-x

Source DB:  PubMed          Journal:  Environ Res        ISSN: 0013-9351            Impact factor:   6.498


  4 in total

1.  Assessment of the pathogenic potential of asbestiform vs. nonasbestiform particulates (cleavage fragments) in in vitro (cell or organ culture) models and bioassays.

Authors:  Brooke T Mossman
Journal:  Regul Toxicol Pharmacol       Date:  2007-10-11       Impact factor: 3.271

Review 2.  In vitro assessment of biopersistence using mammalian cell systems.

Authors:  M C Jaurand
Journal:  Environ Health Perspect       Date:  1994-10       Impact factor: 9.031

Review 3.  Quantification of short and long asbestos fibers to assess asbestos exposure: a review of fiber size toxicity.

Authors:  Guillaume Boulanger; Pascal Andujar; Jean-Claude Pairon; Marie-Annick Billon-Galland; Chantal Dion; Pascal Dumortier; Patrick Brochard; Annie Sobaszek; Pierre Bartsch; Christophe Paris; Marie-Claude Jaurand
Journal:  Environ Health       Date:  2014-07-21       Impact factor: 5.984

Review 4.  Review of animal/in vitro data on biological effects of man-made fibers.

Authors:  S A Ellouk; M C Jaurand
Journal:  Environ Health Perspect       Date:  1994-06       Impact factor: 9.031

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.